ArticleTranslational lung cancer research2024

Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients.

Noriyuki Ebi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.